Recent discoveries

Drs. Hashemi and Mirsaeidi from Phageolytix have made a notable advancement in medical research by discovering novel bacteriophages that can combat the Pseudomonas aeruginosa bacterium. This pathogen, known for its high resistance to antibiotics, infects millions each year and poses a significant challenge to healthcare. Traditional antibiotic treatments have been insufficient, spurring the need for innovative therapies.

The promising solution lies in phage therapy, which leverages bacteriophages' natural ability to infect and eradicate bacteria, effectively circumventing the issues of antibiotic and biocidal resistance. This discovery presents a potential new method for tackling Pseudomonas aeruginosa infections in humans, animals, and the environment.

This breakthrough demonstrates Phageolytix's dedication to pioneering research and development, driving us closer to overcoming antibiotic resistance. It underscores our commitment to crafting solutions that are not just effective, but also environmentally friendly and sustainable, reinforcing our position as pioneers in phage therapy.